Astrotech (NASDAQ:ASTC) Lowered to Strong Sell Rating by Wall Street Zen

Posted by ABMN Staff on Jun 13th, 2026

Astrotech (NASDAQ:ASTC – Get Free Report) was downgraded by research analysts at Wall Street Zen to a “strong sell” rating in a research report issued on Saturday.

Separately, Weiss Ratings raised shares of Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Astrotech currently has a consensus rating of “Sell”.

Check Out Our Latest Stock Report on ASTC

Astrotech Stock Down 28.3%

Shares of Astrotech stock opened at $19.01 on Friday. Astrotech has a twelve month low of $1.91 and a twelve month high of $68.85. The business has a 50-day moving average price of $10.48 and a 200-day moving average price of $5.77. The firm has a market cap of $34.22 million, a price-to-earnings ratio of -2.26 and a beta of 4.60.

Astrotech (NASDAQ:ASTC – Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%. The business had revenue of $0.34 million during the quarter.

Hedge Funds Weigh In On Astrotech

Institutional investors have recently bought and sold shares of the business. Susquehanna International Group LLP purchased a new position in Astrotech during the third quarter valued at approximately $66,000. DRW Securities LLC increased its position in shares of Astrotech by 168.5% during the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock worth $109,000 after purchasing an additional 19,747 shares in the last quarter. Finally, J. Safra Sarasin Holding AG acquired a new position in shares of Astrotech in the 1st quarter valued at $140,000. 24.35% of the stock is owned by hedge funds and other institutional investors.

About Astrotech

(Get Free Report)

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.